|
|
|
|
LEADER |
01655nam a2200253 u 4500 |
001 |
EB002153031 |
003 |
EBX01000000000000001291157 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
230403 r ||| eng |
020 |
|
|
|a 9789240057302
|
020 |
|
|
|a 9789240057296
|
245 |
0 |
0 |
|a WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes
|h Elektronische Ressource
|
246 |
3 |
1 |
|a Antenatal corticosteroids for improving preterm birth outcomes
|
260 |
|
|
|a Geneva
|b World Health Organization
|c 2022, [2022]
|
300 |
|
|
|a 1 PDF file (viii, 29 pages)
|
505 |
0 |
|
|a Includes bibliographical references
|
710 |
2 |
|
|a World Health Organization
|
710 |
2 |
|
|a Special Programme of Research, Development, and Research Training in Human Reproduction (World Health Organization)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK585366
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of antenatal corticosteroids as published in the WHO recommendations on interventions to improve preterm birth outcomes. This decision was based on new evidence on the subject that had become available. The recommendations in this document thus supersedes the previous WHO recommendations on the use of antenatal corticosteroids as published in the 2015 guidelines, WHO recommendations on interventions to improve preterm birth outcomes
|